Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing DSSTox_CID_28917 in Europe. Original Data : EMA Website

Menu
$ API Ref.Price (USD/KG) : 417,144Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Accord Healthcare Ltd.

02 2FERRING PHARMACEUTICALS A/S

03 2Ferring Pharmaceuticals A / S

04 2Ferring Pharmaceuticals AS

05 2SUN PHARMACEUTICAL IND.EU.B.V.

06 2Stragen Nordic A/S

07 2Sun Pharmaceutical - Netherlands

08 2Sun Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Atosiban acetate

Brand Name : atosiban Accord

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 37.5 MG / 5 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Atosiban acetate

Brand Name : TRACTOCILE

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 6.75 MG / 0.9 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Atosiban acetate

Brand Name : TRACTOCILE

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 37.5 MG / 5 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

atosiban

Brand Name : Tractocile

Dosage Form : Atosiban 37.5 Mg 5Ml 1 Units Parenteral Use

Dosage Strength : 1 ampoule EV 5 ml 37.5 mg/5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

05

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Atosiban acetate

Brand Name : Tractocile

Dosage Form : Atosiban 6,75Mg 0,9Ml 1 Unit Parenteral Use

Dosage Strength : 1 ampoule EV 0.9 ml 6.75 mg/0.9 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

atosiban

Brand Name : Atos Iban Stragen

Dosage Form : Concentrate to the infusion fluid, resolution

Dosage Strength : 37.5 mg/5 ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Atosiban acetate

Brand Name : atosiban SUN

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 6.75 MG / 0.9 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

08

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

Atosiban acetate

Brand Name : atosiban SUN

Dosage Form : CONCENTRATE FOR SOLUTION FOR INFUSION

Dosage Strength : 37.5 MG / 5 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

09

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

atosiban

Brand Name : Atosiban

Dosage Form : Atosiban 37.5 Mg 5Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 37.5 mg/5 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

atosiban

Brand Name : Atosiban

Dosage Form : Atosiban 6,75Mg 0,9Ml 1 Unit Parenteral Use

Dosage Strength : 1 vial EV 6.75 mg/0.9 ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank